World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
64902
World Ranking
6899
National Ranking
3639

Overview

Celestia S. Higano is a researcher affiliated with the University of Washington in the United States, focusing primarily on medicine with a substantial number of publications in oncological fields. Their research encompasses several subfields, including pulmonary and respiratory medicine, oncology, radiology, nuclear medicine and imaging, cancer research, and endocrinology, diabetes, and metabolism.

The core topics of Higano's work center on prostate cancer treatment and research, with significant contributions to understanding radiopharmaceutical chemistry and applications. Other main research areas include cancer survivorship and care, prostate cancer diagnosis and treatment, PARP inhibition in cancer therapy, cancer lipids and metabolism, and cancer genomics and diagnostics.

Higano has published extensively in several scientific journals, with frequent publication venues including:

  • Journal of Clinical Oncology
  • The Journal of Urology
  • European Urology
  • The Journal of Sexual Medicine
  • Prostate Cancer and Prostatic Diseases

Their recent papers reflect a focus on prostate cancer and DNA repair mechanisms. Notable publications include:

  • Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration, 2020, Journal of Clinical Oncology
  • Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study, 2020, Clinical Cancer Research
  • Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019, 2020, European Urology
  • Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial, 2021, The Lancet Oncology
  • Treatment Patterns and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer in a Real-world Clinical Practice Setting in the United States, 2020, Clinical Genitourinary Cancer

Higano has collaborated frequently with several co-authors notable within the same research domain. These collaborators include Oliver Sartor, Fred Saad, Karim Fizazi, Neal D. Shore, and Johann S. de Bono.

Best Publications

  • Sipuleucel-T immunotherapy for castration-resistant prostate cancer.

    Philip W. Kantoff;Celestia S. Higano;Neal D. Shore;E. Roy Berger

  • Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

    Tomasz M Beer;Andrew J Armstrong;Dana E Rathkopf;Yohann Loriot

  • Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

    Charles J. Ryan;Matthew R. Smith;Johann S. De Bono;Arturo Molina

  • Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer

    Chris Tran;Samedy Ouk;Nicola J. Clegg;Yu Chen

  • Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group.

    Howard I. Scher;Susan Halabi;Ian Tannock;Michael Morris

  • Placebo-Controlled Phase III Trial of Immunologic Therapy with Sipuleucel-T (APC8015) in Patients with Metastatic, Asymptomatic Hormone Refractory Prostate Cancer

    Eric J. Small;Paul F. Schellhammer;Celestia S. Higano;Charles H. Redfern

  • Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth

    R. Bruce Montgomery;Elahe A. Mostaghel;Robert Vessella;David L. Hess

  • Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

    Howard I. Scher;Michael J. Morris;Walter M. Stadler;Celestia Higano

  • Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update

    Ian Thompson;James Brantley Thrasher;Gunnar Aus;Arthur L. Burnett

  • Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study.

    Howard I Scher;Tomasz M Beer;Celestia S Higano;Aseem Anand

  • Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

    James L. Mohler;Emmanuel S. Antonarakis;Andrew J. Armstrong;Anthony V. D'Amico

  • Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study

    Charles J. Ryan;Matthew R. Smith;Karim Fizazi;Fred Saad

  • Quantitative and stoichiometric analysis of the microRNA content of exosomes.

    John R. Chevillet;Qing Kang;Ingrid K. Ruf;Hilary A. Briggs

  • Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with Sipuleucel-T in advanced prostate cancer

    Celestia S. Higano;Paul F. Schellhammer;Eric J. Small;Patrick A. Burch

  • PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine

    Martin A. Cheever;Celestia S. Higano

  • Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B

    Yu Sun;Judith Campisi;Judith Campisi;Celestia Higano;Celestia Higano;Tomasz M Beer

  • Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes

    Michael S. Cookson;Gunnar Aus;Arthur L. Burnett;Edith D. Canby-Hagino

  • Prostate Cancer, Version 1.2016

    James L. Mohler;Andrew J. Armstrong;Robert R. Bahnson;Anthony Victor D'Amico

  • Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer

    Akash Kumar;Ilsa Coleman;Colm Morrissey;Xiaotun Zhang

  • Intermittent versus continuous androgen deprivation in prostate cancer.

    Maha Hussain;Catherine M. Tangen;Donna L. Berry;Celestia S. Higano

Frequent Co-Authors

Tomasz M. Beer
Tomasz M. Beer Oregon Health & Science University
Andrew J. Armstrong
Andrew J. Armstrong Duke University
Eric J. Small
Eric J. Small University of California, San Francisco
Robert L. Vessella
Robert L. Vessella University of Washington
Peter S. Nelson
Peter S. Nelson Fred Hutchinson Cancer Research Center
Fred Saad
Fred Saad University of Montreal
Nicholas J. Vogelzang
Nicholas J. Vogelzang University of Nevada Reno
Cora N. Sternberg
Cora N. Sternberg Cornell University
Karim Fizazi
Karim Fizazi University of Paris-Saclay
Philip W. Kantoff
Philip W. Kantoff Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a medical career in the USA opens doors to various educational pathways beyond the traditional MD route. One increasingly popular option is earning a healthcare administration online degree, ideal for students interested in the business and management side of healthcare.

For registered nurses looking to advance their careers, asn to fnp bridge programs provide a fast track from an associate degree in nursing to a Family Nurse Practitioner role. These flexible programs are designed for working professionals aiming to take on more responsibility in patient care.

Those passionate about nutrition and wellness may pursue the best online food science degree to gain expertise in dietetics, public health, or food safety. This growing field blends science with real-world application to promote healthier communities.

Accreditation is also crucial when choosing a program. Many students ask which online healthcare degree programs are recognized for their accreditation by cahme? Choosing a CAHME-accredited program ensures your education meets the highest industry standards, increasing your career opportunities nationwide.

Best Scientists Citing Celestia S. Higano

Trending Scientists

Recently Published Articles